EMAS

2.540.000

USD/IDR

18.147

IDX

-1.22%

KOMPAS100

-0.96%

LQ45

-0.89%

ISSI

-1.68%

IDX30

-0.67%

IDXHIDIV20

-0.48%

IDX80

-0.84%

IDXV30

-0.70%

IDXQ30

-0.35%

cancer drug

Novartis Wins US Approval for Targeted Cancer Drug Combination

Novartis Wins US Approval for Targeted Cancer Drug Combination

Kamis, 23 Juni 2022 | 16:38 WIB

Loadmore

Terpopuler

1

Efek Premi Risiko Menghantui Rupiah pada Selasa (17/10)

2

Investor Institusi Butuh Pasar yang Lebih Terpercaya